Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Mydecine Innovations Group Inc. was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.

CEO

Mr. David Joshua Bartch

Negara

Kanada

ISIN

CA62849F2008

WKN

000A3DKEJ

Pencatatan

0 Comments

Bagikan pendapatmu

FAQ

Berapa harga saham Mydecine Innovations Group hari ini?▼

Harga saat ini dari 0NF0.F adalah €0.05 EUR — naik sebesar +0% dalam 24 jam terakhir. Pantau kinerja harga saham Mydecine Innovations Group lebih dekat di grafik.

Apa simbol saham Mydecine Innovations Group?▼

Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Mydecine Innovations Group diperdagangkan dengan simbol 0NF0.F.

Berapa pendapatan Mydecine Innovations Group tahun lalu?▼

Pendapatan Mydecine Innovations Group tahun lalu berjumlah 0 EUR.

Berapa pendapatan bersih Mydecine Innovations Group tahun lalu?▼

Pendapatan bersih 0NF0.F untuk tahun lalu adalah -2.15M EUR.

Mydecine Innovations Group berada di sektor apa?▼

Mydecine Innovations Group beroperasi di sektor Kesehatan & Kebugaran.

Kapan Mydecine Innovations Group menyelesaikan split saham?▼

Pemecahan saham terakhir Mydecine Innovations Group terjadi pada Oktober 21, 2025 dengan rasio 1:50.

Di mana kantor pusat Mydecine Innovations Group?▼

Kantor pusat Mydecine Innovations Group berlokasi di Vancouver, Kanada.